Clinical trials: Therapeutic Treatment of Inhalation Anthrax
- Condition Therapeutic Treatment of Inhalation Anthrax
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Inhalational Anthrax
A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients
This study will evaluate safety and clinical benefit of AIGIV used for treatment of patients with inhalational anthrax. This study will be implemented only in the event of a major anthrax exposure event.
- Trial name
- NCT03569553
- Testing
- AIGIV
- Volunteers
- 100 people
- Sponsor
- Emergent BioSolutions